Wellmarker Bio Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $15.4M
Latest Deal Amount
  • Investors
  • 17

Wellmarker Bio General Information

Description

Developer of anticancer drugs intended to address unmet medical needs. The company develops predictive biomarkers and first-in-class drugs through profound research know-hows and clinical information, thereby enabling medical practitioners to bring a better outcome and contribute to the healthy life of patients.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 7th floor, NH Songpa nonghyup Building
  • 155 Songpa-daero, Songpa-gu
  • Seoul, 05855
  • South Korea
+82 00-0000-0000

Wellmarker Bio Timeline

2017201820192020
Date FoundedFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Wellmarker Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 08-Jul-2019 $15.4M 000.00 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 08-Oct-2018 000.00 000.00 Completed Pre-Clinical Trials
1. Seed Round 01-Apr-2018 $4.34M $4.34M Completed Pre-Clinical Trials
To view Wellmarker Bio’s complete valuation and funding history, request access »

Wellmarker Bio Executive Team (1)

Name Title Board Seat Contact Info
Jin Dong-Hoon Founder & Chief Executive Officer
To view Wellmarker Bio’s complete executive team members history, request access »

Wellmarker Bio Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Brick Investment Partners PE/Buyout Minority 000 0000 000000 0
Cytogen (south Korea) Venture Capital Minority 000 0000 000000 0
HB Investments Venture Capital Minority 000 0000 000000 0
NH Investment & Securities PE/Buyout Minority 000 0000 000000 0
Orbit Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »